- Home
- AGNC vs BMRN Comparison
AGNC vs BMRN Comparison
Compare AGNC & BMRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AGNC | BMRN |
|---|---|---|
| Founded | 2008 | 1996 |
| Country | United States | United States |
| Employees | 54 | 3221 |
| Industry | Real Estate Investment Trusts | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.1B | 10.8B |
| IPO Year | N/A | 1999 |
Fundamental Metrics
Financial Performance| Metric | AGNC | BMRN |
|---|---|---|
| Price | $10.47 | $54.55 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 12 | 18 |
| Target Price | $10.92 | ★ $88.22 |
| AVG Volume (30 Days) | ★ 19.0M | 1.7M |
| Earning Date | 04-20-2026 | 04-30-2026 |
| Dividend Yield | ★ 13.74% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 1.80 |
| Revenue | N/A | ★ $1,313,646,000.00 |
| Revenue This Year | N/A | $15.02 |
| Revenue Next Year | $0.51 | $12.23 |
| P/E Ratio | ★ $7.69 | $31.27 |
| Revenue Growth | N/A | ★ 17.62 |
| 52 Week Low | $8.07 | $50.76 |
| 52 Week High | $12.19 | $66.28 |
Technical Indicators
Market Signals| Indicator | AGNC | BMRN |
|---|---|---|
| Relative Strength Index (RSI) | 52.68 | 40.75 |
| Support Level | $10.16 | $53.71 |
| Resistance Level | $10.66 | $56.21 |
| Average True Range (ATR) | 0.22 | 1.33 |
| MACD | 0.10 | 0.13 |
| Stochastic Oscillator | 89.67 | 26.33 |
Price Performance
Historical ComparisonAbout AGNC AGNC Investment Corp.
AGNC Investment Corp is a real estate investment trust that invests in agency residential mortgage-backed securities. The firm's asset portfolio is comprised of residential mortgage pass-through securities and collateralized mortgage obligations for which the principal and interest payments are guaranteed by a U.S. Government-sponsored enterprise, such as the Federal National Mortgage Association and the Federal Home Loan Mortgage Corporation, or by a U.S. Government agency, such as the Government National Mortgage Association. It also invests in other types of mortgage and mortgage-related residential and commercial mortgage-backed securities or other investments in or related to, the housing, mortgage, or real estate markets.
About BMRN BioMarin Pharmaceutical Inc.
BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments designed to address complex genetic disorders. The company has eight approved therapies for conditions including achondroplasia, phenylketonuria, hemophilia, and mucopolysaccharidosis. BioMarin has an expanding, yet relatively early-stage, pipeline of treatments in development across skeletal conditions and enzyme therapies.